PLAT and androgen insensitivity syndrome: The SolitaireTM with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial is being undertaken to establish the safety and efficacy of neurothrombectomy with Solitaire in conjunction with IV tPA vs. IV tPA alone, among AIS patients treatable within six-hours of symptom onset.